drugset / Trial / NCT00966316

Establishment and Evaluation to the Effects of a Clinical Pathway for Acute Ischemic Stroke

NCT00966316 ↗

Non-randomizedParallel-groupOpen-labelTreatment

Summary

The purpose of this study is to determine whether the clinical pathway for acute ischemic stroke(with combination of traditional Chinese medicine and western medicine) is able to improve the outcome of acute ischemic stroke and evaluate its effect on hospital day and cost, etc. Meanwhile, the study will discuss the safety and efficiency of this kind of Clinical Pathway

Timeline

Start
2009-05
Primary completion
2010-08
Completion
2011-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Aspirin Small molecule 100 mg —
Subject Aspirin Small molecule 300 mg —

Indications